Biogen Medical Research
The following area of research is currently being considered with a focus on Multiple Sclerosis:
Biogen MS therapies include the following products:
The following areas of research are currently being considered with a focus on:
The following areas of research are not currently being considered for funding:
Please note that new study proposals originating in Argentina, Australia, Bahrain, Brazil, Bosnia and Hercegovina, Bulgaria, Chile, China, Colombia, Cyprus, Greece, Israel, Japan, Kingdom of Saudi Arabia, Kuwait, Mexico, Montenegro, New Zealand, North Macedonia, Oman, Qatar, Romania, Serbia, United Arab Emirates, and Uruguay are currently not eligible for funding. Investigators from Israel and Greece or Cyprus may reach out to our Partners (Medison and Genesis, respectively) with inquiries for funding.
Research support is awarded on a highly competitive basis, and submission of research proposals in these areas of interest does not guarantee support will be awarded.